课题基金 / 基金详情

Nrf2通过调控CYP2E1蛋白稳定性在硫代乙酰胺致肝损伤中的作用与机制研究

批准号:
82103889
项目类别:
青年科学基金项目(C类)
资助金额:
30.0 万元
负责人:
武瑞瑞
依托单位:
学科分类:
卫生毒理
结题年份:
2024
批准年份:
2021
项目状态:
已结题
项目参与者:
武瑞瑞

项目摘要

结项摘要

相似基金

相关文献

中文摘要
硫代乙酰胺(TAA)是一种广泛用于工农业生产的化学物,具有肝脏毒性,但其毒作用分子机制尚不完全清楚。核因子E2相关因子2(Nrf2)作为调控抗氧化反应的重要转录因子,通常在防御化学物所致肝损伤中发挥保护作用。然而我们在前期研究中发现,TAA急性暴露后,Nrf2缺失小鼠肝损伤减轻,同时TAA代谢活化关键酶CYP2E1蛋白水平降低,提示Nrf2可能通过调控CYP2E1参与TAA代谢活化进而影响肝损伤。本项目拟将体内外实验相结合,以Nrf2调控CYP2E1蛋白稳定性为切入点,探讨Nrf2在TAA致肝损伤中的作用和机制:以Nrf2基因敲除小鼠为研究对象阐明Nrf2在TAA代谢活化及其所致肝损伤中的作用;通过原代肝细胞进一步解析Nrf2通过ROS-Heme途径对CYP2E1蛋白稳定性的调控机制,为TAA及其同类毒物肝毒性的干预策略和方法提供科学依据。
英文摘要
Thioacetamide (TAA), a chemical with hepatoxicity, is widely used in industrial and agricultural production, but the molecular mechanism of its toxicity is incompletely understood. As a crucial transcription factor in antioxidative defense, nuclear factor-E2-related factor 2 (Nrf2) is of great concern in defensing against chemical-induced hepatic injury. However, in our previous studies, we found that Nrf2 deficient mice were resistant to TAA-induced acute liver injury, and showed reduced protein level of CYP2E1, a key enzyme for TAA metabolic activation. These data indicate that Nrf2 may participates in TAA metabolic activation through regulating CYP2E1, and thereby is involved in TAA-induced liver injury. Thus, this project aims to explore the role and mechanism of Nrf2 in TAA-induced liver injury from the viewpoint of protein stability of CYP2E1 with in vivo and in vitro methods: Nrf2 knockout mice will be applied to clarify the role of Nrf2 in metabolic activation and liver injury of TAA; the primary mouse hepatocytes will be used to elucidate the mechanism of Nrf2 on regulating protein stability of CYP2E1 through the ROS-Heme pathway. The project will provide a scientific basis for intervention strategies and methods of hepatotoxicity induced by TAA and similar toxicants.
硫代乙酰胺(TAA)是典型的肝脏损伤毒物,目前TAA所致肝损伤的具体机制远未阐明,制约其有效防治技术和手段的建立。先前的研究表明,TAA诱导的肝毒性与生物活性和氧化应激有关。Nrf2作为一种重要的转录因子,在防御化学性肝损伤方面备受关注。因此本研究旨在探讨抗氧化转录因子E2相关因子2(Nrf2)在TAA及同类化学物所致肝损伤中的作用及机制。在本研究中,我们发现当Nrf2缺失时,由于急性暴露期肝损伤减轻,小鼠对TAA诱导的肝纤维化具有抵抗力。然而,Nrf2-KO小鼠的抗氧化防御能力低于Nrf2-WT小鼠。Nrf2-KO小鼠尿液氧化代谢物和肝脏代谢标记物乙酰赖氨酸所反映的TAA生物活性显著低于Nrf2-WT小鼠。同时,我们发现Nrf2缺失抑制DEN代谢活化,进而减弱DEN所致小鼠肝损伤效应;Nrf2激动剂处理促进DEN代谢活化,进而加重DEN所致肝脏DNA损伤。Nrf2缺失加速了CYP2E1蛋白的降解,同时增加了ROS水平,进而减轻经CYP2E1介导代谢活化的化学物所致肝损伤效应。本项目结果为TAA及其同类毒物肝毒性有效防治技术的开发提供基础性实验依据,同时提示应谨慎使用调节Nrf2ARE途径的抗氧化剂,以应对这类化学物质。
国内基金
海外基金